Glycosylation potential of human prostate cancer cell lines

Glycoconjugate Journal

Volumn 29, Issue 7, 2012, Pages 525-537

  Gao, Yin ^a   Chachadi, Vishwanath B ^b,c   Cheng, Pi Wan ^b,c   Brockhausen, Inka ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Glycosyltransferase activities; N glycosylation; O glycosylation; Prostate cancer cells; Real Time PCR

Indexed keywords

GLYCAN DERIVATIVE; GLYCOSYLTRANSFERASE; MESSENGER RNA; N GLYCAN; O GLYCAN; SULFOTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE EXPRESSION; GLYCOSYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ASSEMBLY; PROTEIN SYNTHESIS;

CACO-2 CELLS; GLYCOPROTEINS; GLYCOSYLATION; GLYCOSYLTRANSFERASES; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; SULFOTRANSFERASES;

EID: 84865739859     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-012-9428-8     Document Type: Article

References (62)

1. Bresalier, R.S., Ho, S.B., Schoeppner, H.L., Kim, Y.S., Sleisenger, M.H., Brodt, P., Byrd, J.C.: Enhanced sialylation of mucinassociated carbohydrate structures in human colon cancer metastasis. Gastroenterology 110, 1354-1367 (1996) (Pubitemid 26134066)
2. Burke, P.A., Gregg, J.P., Bakhtiar, B., Beckett, L.A., Denardo, G.L., Albrecht, H., De Vere White, R.W., De Nardo, S.J.: Characterization of MUC1 glycoprotein on prostate cancer for selection of targeting molecules. Int. J. Oncol. 29, 49-55 (2006)
3. Garbar, C., Mascaux, C., Wespes, E.: Expression of MUC1 and sialyl-Tn in benign prostatic glands, high-grade prostate intraepithelial neoplasia and malignant prostatic glands: a preliminary study. Anal. Quant. Cytol. Histol. 30, 71-77 (2008) (Pubitemid 351501866)
4. Tabarés, G., Radcliffe, C.M., Barrabés, S., Ramírez, M., Aleixandre, R.N.,Hoesel,W.,Dwek, R.A., Rudd, P.M., Peracaula, R., de Llorens, R.: Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. Glycobiology 16, 132-145 (2006) (Pubitemid 43125969)
5. Barthel, S.R., Gavino, J.D.,Wiese, G.K., Jaynes, J.M., Siddiqui, J., Dimitroff, C.J.: Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin. Glycobiology 18, 806-817 (2008)
6. Barthel, S.R., Wiese, G.K., Cho, J., Opperman, M.J., Hays, D.L., Siddiqui, J., Pienta, K.J., Furie, B., Dimitroff, C.J.: Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking. Proc. Natl. Acad. Sci. U. S. A. 106, 19491-19496 (2009)
7. Brockhausen, I.: Mucin-Type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep. 7, 599-604 (2006) (Pubitemid 43827326)
8. Carraway, K.L., Fregien, N., Carraway, C.A.: Tumor sialomucin complexes as tumor antigens and modulators of cellular interactions and proliferation. J. Cell Sci. 103(Pt 2), 299-307 (1992)
9. David, L., Nesland, J.M., Clausen, H., Carneiro, F., Sobrinho- Simões, M.: Simple mucin-Type carbohydrate antigens (Tn, sialosyl-Tn and T) in gastric mucosa, carcinomas and metastases. APMIS Suppl. 27, 162-172 (1992)
10. Hoff, S.D., Matsushita, Y., Ota, D.M., Cleary, K.R., Yamori, T., Hakomori, S., Irimura, T.: Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma. Cancer Res. 49, 6883-6888 (1989) (Pubitemid 20016561)
11. Kojima, N., Handa, K., Newman, W., Hakomori, S.: Inhibition of selectin-dependent tumor cell adhesion to endothelial cells and platelets by blocking O-glycosylation of these cells. Biochem. Biophys. Res. Commun. 182, 1288-1295 (1992)
12. Radhakrishnan, P., Lin, M.F., Cheng, P.W.: Elevated expression of L-selectin ligand in lymph node-derived human prostate cancer cells correlates with increased tumorigenicity. Glycoconj. J. 26, 75-81 (2009)
13. Takano, R., Muchmore, E., Dennis, J.W.: Sialylation and malignant potential in tumour cell glycosylation mutants. Glycobiology 4, 665-674 (1994) (Pubitemid 24327732)
14. Itzkowitz, S.H., Bloom, E.J., Kokal, W.A., Modin, G., Hakomori, S., Kim, Y.S.: Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 66, 1960-1966 (1990) (Pubitemid 20385969)
15. Janković, M.M., Kosanović, M.M.: Glycosylation of urinary prostate-specific antigen in benign hyperplasia and cancer: assessment by lectin-binding patterns. Clin. Biochem. 38, 58-65 (2005) (Pubitemid 39647657)
16. Peracaula, R., Tabarés, G., Royle, L., Harvey, D.J., Dwek, R.A., Rudd, P.M., de Llorens, R.: Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. Glycobiology 13, 457-470 (2003) (Pubitemid 36665420)
17. Cozzi, P.J., Wang, J., Delprado, W., Perkins, A.C., Allen, B.J., Russell, P.J., Li, Y.: MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. Clin. Exp. Metastasis 22, 565-573 (2005) (Pubitemid 43234641)
18. Singh, A.P., Chauhan, S.C., Bafna, S., Johansson, S.L., Smith, L.M., Moniaux, N., Lin, M.F., Batra, S.K.: Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas. Prostate 66, 421-429 (2006) (Pubitemid 43348735)
19. Wu, G.J., Peng, Q., Fu, P., Wang, S.W., Chiang, C.F., Dillehay, D.L.,Wu, M.W.: Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells. Gene 327, 201-213 (2004) (Pubitemid 38230115)
20. Bélanger, A., van Halbeek, H., Graves, H.C., Grandbois, K., Stamey, T.A., Huang, L., Poppe, I., Labrie, F.: Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard. Prostate 27, 187-197 (1995)
21. Meany, D.L., Zhang, Z., Sokoll, L.J., Zhang, H., Chan, D.W.: Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns. J. Proteome Res. 8, 613-619 (2009)
22. Ohyama, C., Hosono, M., Nitta, K., Oh-eda, M., Yoshikawa, K., Habuchi, T., Arai, Y., Fukuda, M.: Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy. Glycobiology 14, 671-679 (2004) (Pubitemid 39161974)
23. St Hill, C.A., Farooqui, M., Mitcheltree, G., Gulbahce, H.E., Jessurun, J., Cao, Q., Walcheck, B.: The high affinity selectin glycan ligand C2-O-SLex and mRNA transcripts of the core 2 beta-1,6-N-Acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas. BMC Cancer 9, 79 (2009)
24. Shimodaira, K., Nakayama, J., Nakamura, N., Hasebe, O., Katsuyama, T., Fukuda, M.: Carcinoma-Associated expression of core 2 beta-1,6-N- Acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression. Cancer Res. 57, 5201-5206 (1997) (Pubitemid 27516348)
25. Hanski, C., Klussmann, E., Wang, J., Böhm, C., Ogorek, D., Hanski, M.L., Krüger-Krasagakes, S., Eberle, J., Schmitt-Gräff, A., Riecken, E.O.: Fucosyltransferase III and sialyl-Le(x) expression correlate in cultured colon carcinoma cells but not in colon carcinoma tissue. Glycoconj. J. 13, 727-733 (1996) (Pubitemid 26354265)
26. Ito, H., Hiraiwa, N., Sawada-Kasugai, M., Akamatsu, S., Tachikawa, T., Kasai, Y., Akiyama, S., Ito, K., Takagi, H., Kannagi, R.: Altered mRNA expression of specific molecular species of fucosyl-And sialyl-Transferases in human colorectal cancer tissues. Int. J. Cancer 71, 556-564 (1997) (Pubitemid 27239364)
27. Nakamori, S., Kameyama, M., Imaoka, S., Furukawa, H., Ishikawa, O., Sasaki, Y., Kabuto, T., Iwanaga, T., Matsushita, Y., Irimura, T.: Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res. 53, 3632-3637 (1993) (Pubitemid 23229648)
28. Machida, E., Nakayama, J., Amano, J., Fukuda, M.: Clinicopathological significance of core 2 beta1,6-N-Acetylglucosaminyltransferase messenger RNA expressed in the pulmonary adenocarcinoma determined by in situ hybridization. Cancer Res. 61, 2226-2231 (2001) (Pubitemid 32692052)
29. Hagisawa, S., Ohyama, C., Takahashi, T., Endoh, M., Moriya, T., Nakayama, J., Arai, Y., Fukuda, M.: Expression of core 2 beta1,6-N- Acetylglucosaminyltransferase facilitates prostate cancer progression. Glycobiology 15, 1016-1024 (2005) (Pubitemid 41511496)
30. Valenzuela, H.F., Pace, K.E., Cabrera, P.V., White, R., Porvari, K., Kaija, H., Vihko, P., Baum, L.G.: O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1. Cancer Res. 67, 6155-6162 (2007) (Pubitemid 47037496)
31. Brockhausen, I.: Pathways of O-glycan biosynthesis in cancer cells. Biochim. Biophys. Acta 1473, 67-95 (1999)
32. Brockhausen, I.: Comprehensive Natural Products II Chemistry and Biology. In: Mander, L., Lui, H.-W., Wang, P.G. (eds.) Biosynthesis of complex mucin-Type O-glycans. Carbohydrates, nucleosides and nucleic acids, vol. 6, pp. 315-350. Elsevier, Oxford (2010). Chapter 11
33. Burchell, J., Poulsom, R., Hanby, A., Whitehouse, C., Cooper, L., Clausen, H., Miles, D., Taylor-Papadimitriou, J.: An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas. Glycobiology 9, 1307-1311 (1999) (Pubitemid 30011510)
34. Petretti, T., Kemmner, W., Schulze, B., Schlag, P.M.: Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases. Gut 46, 359-366 (2000) (Pubitemid 30313387)
35. Seko, A., Ohkura, T., Kitamura, H., Yonezawa, S., Sato, E., Yamashita, K.: Quantitative differences in GlcNAc:beta1->3 and GlcNAc:beta1->4 galactosyltransferase activities between human colonic adenocarcinomas and normal colonic mucosa. Cancer Res. 56, 3468-3473 (1996) (Pubitemid 26251638)
36. Yang, J.M., Byrd, J.C., Siddiki, B.B., Chung, Y.S., Okuno, M., Sowa, M., Kim, Y.S., Matta, K.L., Brockhausen, I.: Alterations of O-glycan biosynthesis in human colon cancer tissues. Glycobiology 4, 873-884 (1994)
37. Vavasseur, F., Dole, K., Yang, J., Matta, K.L., Myerscough, N., Corfield, A., Paraskeva, C., Brockhausen, I.: O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Eur. J. Biochem. 222, 415-424 (1994) (Pubitemid 24204910)
38. Vavasseur, F., Yang, J.M., Dole, K., Paulsen, H., Brockhausen, I.: Synthesis of O-glycan core 3: characterization of UDP-GlcNAc: GalNAc-R beta 3-N-Acetyl-glucosaminyltransferase activity from colonic mucosal tissues and lack of the activity in human cancer cell lines. Glycobiology 5, 351-357 (1995)
39. Brockhausen, I., Romero, P., Herscovics, A.: Glycosyltransferase changes upon differentiation of CaCo-2 human colonic adenocarcinoma Cells. Cancer Res. 51, 3136-3142 (1991)
40. Brockhausen, I., Benn, M., Bhat, S., Marone, S., Riley, J.G., Montoya-Peleaz, P., Vlahakis, J.Z., Paulsen, H., Schutzbach, J.S., Szarek, W.A.: UDP-Gal: GlcNAc-R beta1,4-galactosyltransferase-A target enzyme for drug design. Acceptor specificity and inhibition of the enzyme. Glycoconj. J. 23, 525-541 (2006) (Pubitemid 44477396)
41. Brockhausen, I., Reck, F., Kuhns, W., Khan, S., Matta, K.L., Meinjohanns, E., Paulsen, H., Shah, R.N., Baker, M.A., Schachter, H.: Substrate specificity and inhibition of UDP-GlcNAc:GlcNAc beta 1-2Man alpha 1-6R beta 1,6-N-Acetylglucosaminyltransferase V using synthetic substrate analogues. Glycoconj. J. 12, 371-379 (1995)
42. Brockhausen, I., Dowler, T., Paulsen, H.: Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2. Biochim. Biophys. Acta 1790, 1244-1257 (2009)
43. Tassone, F., Hagerman, R.J., Taylor, A.K., Gane, L.W., Godfrey, T.E., Hagerman, P.J.: Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am. J. Hum. Genet. 66, 6-15 (2000) (Pubitemid 30481464)
44. Yang, X., Yip, J., Harrison, M., Brockhausen, I.: Primary human osteoblasts and bone cancer cells as models to study glycodynamics in bone. Int. J. Biochem. Cell Biol. 40, 471-483 (2008) (Pubitemid 351249885)
45. Brown, J.R., Fuster, M.M., Li, R., Varki, N., Glass, C.A., Esko, J.D.: A disaccharide-based inhibitor of glycosylation attenuates metastatic tumor cell dissemination. Clin. Cancer Res. 12, 2894-2901 (2006)
46. Brockhausen, I., Williams, D., Matta, K.L., Orr, J., Schachter, H.: Mucin Synthesis III: UDP-GlcNAc:Galß1-3(GlcNAcß1-6)Gal-NAc-R (GlcNAc to Gal) β3-N-Acetylglucosaminyltransferase, an enzyme in porcine gastric mucosa involved in the elongation of mucin-Type oligosaccharides. Can. J. Biochem. Cell Biol. 61, 1322-1333 (1983) (Pubitemid 14173951)
47. Gao, Y., Lazar, C., Szarek, W.A., Brockhausen, I.: Specificity of β4galactosyltransferase inhibitor 2-naphthyl 2-butanamido-2-deoxy-1-Thio- β-D-glucopyranoside. Glycoconj. J. 27, 673-684 (2010)
48. Huang, J., Liang, J.T., Huang, H.C., Shen, T.L., Chen, H.Y., Lin, N.Y., Che, M.I., Lin, W.C., Huang, M.C.: Beta1,4-N-Acetylgalactosaminyltransferase III enhances malignant phenotypes of colon cancer cells. Mol. Cancer Res. 5, 543-552 (2007) (Pubitemid 46985045)
49. Yao, M., Zhou, D.P., Jiang, S.M., Wang, Q.H., Zhou, X.D., Tang, Z.Y., Gu, J.X.: Elevated activity of N-Acetylglucosaminyltransferase V in human hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 124, 27-30 (1998) (Pubitemid 28129111)
50. Tsui, K.H., Chang, P.L., Feng, T.H., Chung, L.C., Sung, H.C., Juang, H.H.: Evaluating the function of matriptase and Nacetylglucosaminyltransferase V in prostate cancer metastasis. Anticancer. Res. 28, 1993-1999 (2008)
51. Premaratne, P., Wélen, K., Damber, J.-E., Hansson, G., Bäckström, M.: O-glycosylation of MUC1 mucin in prostate cancer and the effects of its expression on tumor growth in a prostate cancer xenograft model. Tumor Biol. 32, 203-213 (2011)
52. Pinho, S., Marcos, N.T., Ferreira, B., Carvalho, A.S., Oliveira, M.J., Santos-Silva, F., Harduin-Lepers, A., Reis, C.A.: Biological significance of cancer-Associated sialyl-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells. Cancer Lett. 249, 157-170 (2007) (Pubitemid 46452924)
53. Lise, M., Belluco, C., Perera, S.P., Patel, R., Thomas, P., Ganguly, A.: Clinical correlations of alpha2,6-sialyltransferase expression in colorectal cancer patients. Hybridoma 19, 281-286 (2000)
54. Dalziel, M., Whitehouse, C., McFarlane, I., Brockhausen, I., Gschmeissner, S., Schwientek, T., Clausen, H., Burchell, J.M., Taylor-Papadimitriou, J.: The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-Associated epitope on MUC1. J. Biol. Chem. 276, 11007-11015 (2001) (Pubitemid 38089281)
55. Hatakeyama, S., Kyan, A., Yamamoto, H., Okamoto, A., Sugiyama, N., Suzuki, Y., Yoneyama, T., Hashimoto, Y., Koie, T., Yamada, S., Saito, H., Arai, Y., Fukuda, M., Ohyama, C.: Core 2 Nacetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor. Int. J. Cancer 127, 1052-1059 (2010)
56. Iwai, T., Kudo, T., Kawamoto, R., Kubota, T., Togayachi, A., Hiruma, T., Okada, T., Kawamoto, T., Morozumi, K., Narimatsu, H.: Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 102, 4572-4577 (2005) (Pubitemid 40397153)
57. Lee, S.H., Hatakeyama, S., Yu, S.Y., Bao, X., Ohyama, C., Khoo, K.H., Fukuda, M.N., Fukuda, M.: Core 3 O-glycan synthase suppresses tumor formation and metastasis of prostate carcinoma PC3 and LNCaP cells through down-regulation of alpha2beta1 integrin complex. J. Biol. Chem. 284, 17157-17169 (2009)
58. An, G., Wei, B., Xia, B., McDaniel, J.M., Ju, T., Cummings, R.D., Braun, J., Xia, L.: Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J. Exp. Med. 240, 1417-1429 (2007) (Pubitemid 46919879)
59. Brockhausen, I., Yang, J.M., Burchell, J., Whitehouse, C., Taylor-Papadimitriou, J.: Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur. J. Biochem. 233, 607-617 (1995)
60. Cazet, A., Julien, S., Bobowski, M., Krzewinski-Recchi, M.A., Harduin-Lepers, A., Groux-Degroote, S., Delannoy, P.: Consequences of the expression of sialylated antigens in breast cancer. Carbohydr. Res. 345, 1377-1383 (2010)
61. Mungul, A., Cooper, L., Brockhausen, I., Ryder, K., Mandel, U., Clausen, H., Rughetti, A., Miles, D.W., Taylor-Papadimitriou, J., Burchell, J.M.: Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice. Int. J. Oncol. 25, 937-943 (2004)
62. Picco, G., Julien, S., Brockhausen, I., Beatson, R., Antonopoulos, A., Haslam, S.,Mandel,U.,Dell,A., Pinder, S., Taylor-Papadimitriou, J., Burchell, J.: Over-expression of ST3Gal-I promotes mammary tumorigenesis. Glycobiology 20, 1241-1250 (2010)